Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW340 (Pelubiprofen/Eperisone) in Acute Low Back Pain
NCT03424707Phase 2Completed
- Sponsor
- Daewon Pharm
- Start
- Mar 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pelubiprofen, eperisone in acute low back pain, sponsored by Daewon Pharm. Started Mar 2016; status: completed.
02
Drugs
pelubiprofeneperisone
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT03424707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03424707.